Search For "approval"
mRNA vaccine testing for Omicron subject to regulatory approvals: Gennova
Updated : 4 years, 2 months ago IST
New Delhi [India], January 17 (ANI): The testing of Gennova Biopharmaceutical's mRNA vaccine for the Omicron variant of COVID-19 is subject to regulatory approvals, the company's official spokesperson informed on Monday.
Read More
Peptech Biosciences Ltd. receives grant of registration for Paclobutrazole
Updated : 4 years, 2 months ago IST
New Delhi [India], January 17 (ANI/NewsVoir): Peptech Biosciences Limited (ISO 9001:2015) is pleased to announce that they have received the approval for the grant of registration for Technical Indigenous Manufacture of Paclobutrazol technical 95% w/w min. u/s 9(4). from the Central Insectic
Read More
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 17 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the g
Read More
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More
Glenmark's subsidiary receives NDA Approval by US FDA for Ryaltris™
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) fo
Read More
DCGI's SEC to review applications of Bharat Biotech, SII for full market a
Updated : 4 years, 2 months ago IST
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Read More
Abhinav Immigration received approval for Canada Startup Visa with Family
Updated : 4 years, 2 months ago IST
New Delhi [India], January 12 (ANI/TPT): A historical event in Immigration from India- Abhinav Immigration's Canada Startup Visa group clients get Permanent Residence Visa approval.
Read More
ACA chief Greenberg to accompany Australia players for upcoming tour of Pa
Updated : 4 years, 2 months ago IST
Sydney [Australia], January 11 (ANI): Australian Cricketers Association chief Todd Greenberg has said that he will accompany the country's players in Pakistan should final security approvals for the tour are given.
Read More
Novavax, Serum Institute file for emergency use authorisation of Novavax'
Updated : 4 years, 2 months ago IST
Gaithersburg [US], January 10 (ANI): Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Products Re
Read More
Sandpiper Visas records a 100% success rate in visa approvals
Updated : 4 years, 2 months ago IST
Bangalore (Karnataka) [India], January 10 (ANI/PNN): Sandpiper Visas, a leading immigration consultancy firm in Bangalore and Hyderabad, ranks among the best immigration consultants with a 100% success rate for obtaining the visa approvals for Canada, Australia, UK, UAE and many more coun
Read More
Nepal's COVID Crisis Management Center recommends shutting schools until J
Updated : 4 years, 2 months ago IST
Kathmandu [Nepal], January 9 (ANI): In view of rising COVID-19 cases in Nepal, the COVID Crisis Management Center (CCMC) on Sunday has recommended to the cabinet to shut schools until January 29.
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More